|
Volumn 84, Issue 7, 2001, Pages 875-877
|
Adjuvant therapy for gastric cancer - Has the standard changed?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIRUBICIN;
FLUOROURACIL;
FOLINIC ACID;
MITOMYCIN C;
TEGAFUR;
ANEMIA;
BLOOD TOXICITY;
CANCER ADJUVANT THERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DIARRHEA;
EDITORIAL;
GASTROINTESTINAL DISEASE;
HUMAN;
INFECTION;
LEUKOPENIA;
MUCOSA INFLAMMATION;
NAUSEA;
NEUROTOXICITY;
PRIORITY JOURNAL;
PROGNOSIS;
STOMACH CANCER;
SURGICAL MORTALITY;
SURVIVAL TIME;
THROMBOCYTOPENIA;
VOMITING;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
META-ANALYSIS;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
STOMACH NEOPLASMS;
|
EID: 0035815215
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1054/bjoc.2000.1657 Document Type: Editorial |
Times cited : (3)
|
References (11)
|